IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Investigative Ophthalmology and Visual Science. 2003;44:3502-3510.)
© 2003 by The Association for Research in Vision and Ophthalmology, Inc.
doi:10.1167/iovs.02-0758
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pang, I.-H.
Right arrow Articles by Clark, A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pang, I.-H.
Right arrow Articles by Clark, A. F.

Aqueous Outflow–Enhancing Effect of tert-Butylhydroquinone: Involvement of AP-1 Activation and MMP-3 Expression

Iok-Hou Pang, Debra L. Fleenor, Peggy E. Hellberg, Karen Stropki, Mitchell D. McCartney, and Abbot F. Clark

From Alcon Research, Ltd., Fort Worth, Texas.

PURPOSE. To test the effect of stimulators of activator protein (AP)-1, on expression of stromelysin (MMP-3) in human TM cells and on aqueous outflow in perfused human anterior segments.

METHODS. Change in MMP-3 expression was determined by immunoassay of proMMP-3 levels in the media of cultured human TM cells. Anterior segments of human donor eyes with or without glaucoma were perfused with vehicle or the AP-1 stimulator tert-butylhydroquinone (tBHQ). The outflow rates or intraocular pressure (IOP), and proMMP-3 levels in the perfusate were monitored.

RESULTS. AP-1 stimulators, such as ß-naphthoflavone, 3-methylcholanthrene, and tBHQ, significantly upregulated (2–4-fold) TM cell expression of MMP-3. The stimulatory effect of tBHQ was concentration dependent, with an EC50 of approximately 3 µM, and was blocked by concomitant treatment with 100 nM SR11302, which sequesters AP-1. When nonglaucomatous human eyes were perfused with tBHQ (10 µM), both outflow rates and perfusate proMMP-3 level increased significantly within the first 24 hours. The outflow effect of tBHQ was suppressed when SR11302 (100 nM) was added in the perfusate. tBHQ also lowered the IOP by more than 40% in perfused glaucomatous eyes.

CONCLUSIONS. An AP-1 activator, tBHQ, upregulated expression of MMP-3 in cultured human TM cells and perfused human eyes and enhanced outflow ex vivo. These effects were blocked by sequestering AP-1, suggesting that activation of AP-1 can lead to increased MMP-3 production in the TM, which in turn improves outflow facility. This unique mechanism may provide a novel therapy for glaucoma.




This article has been cited by other articles:


Home page
 IOVSHome page
W.-H. Wang, L. G. McNatt, I.-H. Pang, P. E. Hellberg, J. H. Fingert, M. D. McCartney, and A. F. Clark
Increased Expression of Serum Amyloid A in Glaucoma and Its Effect on Intraocular Pressure
Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1916 - 1923.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
T. Tovar-Vidales, R. Roque, A. F. Clark, and R. J. Wordinger
Tissue Transglutaminase Expression and Activity in Normal and Glaucomatous Human Trabecular Meshwork Cells and Tissues
Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 622 - 628.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. J. Kelley, A. Y. Rose, K. Song, Y. Chen, J. M. Bradley, D. Rookhuizen, and T. S. Acott
Synergism of TNF and IL-1 in the Induction of Matrix Metalloproteinase-3 in Trabecular Meshwork
Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2634 - 2643.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
R. J. Wordinger, D. L. Fleenor, P. E. Hellberg, I.-H. Pang, T. O. Tovar, G. S. Zode, J. A. Fuller, and A. F. Clark
Effects of TGF-{beta}2, BMP-4, and Gremlin in the Trabecular Meshwork: Implications for Glaucoma
Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1191 - 1200.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
D.-J. Oh, J. L. Martin, A. J. Williams, P. Russell, D. E. Birk, and D. J. Rhee
Effect of latanoprost on the expression of matrix metalloproteinases and their tissue inhibitors in human trabecular meshwork cells.
Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3887 - 3895.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. Hosseini, A. Y. Rose, K. Song, C. Bohan, J. P. Alexander, M. J. Kelley, and T. S. Acott
IL-1 and TNF Induction of Matrix Metalloproteinase-3 by c-Jun N-Terminal Kinase in Trabecular Meshwork.
Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1469 - 1476.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
D.-J. Oh, J. L. Martin, A. J. Williams, R. E. Peck, C. Pokorny, P. Russell, D. E. Birk, and D. J. Rhee
Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost.
Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 953 - 963.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
D. L. Fleenor, A. R. Shepard, P. E. Hellberg, N. Jacobson, I.-H. Pang, and A. F. Clark
TGF{beta}2-Induced Changes in Human Trabecular Meshwork: Implications for Intraocular Pressure
Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 226 - 234.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Association for Research in Vision and Ophthalmology